HYBRID EVENT: You can participate in person at Orlando, Florida, USA or Virtually from your home or work.
Health Policy and Advocacy for Endocrinology and Metabolic Diseases

The impact of health policy and advocacy for endocrinology and metabolic diseases extends beyond clinical settings, shaping regulations that improve diabetes care accessibility and affordability. Policymakers work to expand insurance coverage for essential medications, glucose monitoring technologies, and preventive screenings. Advocacy groups push for legislative reforms to address disparities in diabetes management, particularly in low-income and underserved populations. International collaborations aim to standardize guidelines and promote research funding for innovative therapies. By integrating policy-driven approaches with community engagement, healthcare systems can better support individuals with diabetes and endocrine disorders, ensuring equitable access to high-quality care.

Committee Members
Speaker at Diabetes and Endocrinology 2025 - Yong Xiao Wang

Yong Xiao Wang

Albany Medical Center, United States
Speaker at Diabetes and Endocrinology 2025 - F Buck Willis

F Buck Willis

IUHS School of Medicine, Saint Kitts and Nevis
Speaker at Diabetes and Endocrinology 2025 - Gretchen Holmes

Gretchen Holmes

Memorial Hospital at Gulfport, United States
Diabetes 2025 Speakers
Speaker at Diabetes and Endocrinology 2025 - Sujith Rajan

Sujith Rajan

NYU Long Island School of Medicine, United States
Speaker at Diabetes and Endocrinology 2025 - Amy Gutman

Amy Gutman

AdventHealth; Tough Love MD, United States
Speaker at Diabetes and Endocrinology 2025 - Paraskevi Theofilou

Paraskevi Theofilou

Hellenic Open University, Greece
Speaker at Diabetes and Endocrinology 2025 - Clifford Morris

Clifford Morris

Kihealth, United States
Tags

Submit your abstract Today

Watsapp